We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Bioventus Acquires CartiHeal and its Knee Joint Device for Up to $450 Million
Bioventus Acquires CartiHeal and its Knee Joint Device for Up to $450 Million
Durham, N.C.-based Bioventus is buying CartiHeal and its Agili-C implant for knee-joint cartilage surface lesions, a breakthrough device which recently received the FDA’s premarket approval.